Timothy A Gleason, DO | |
250 Hospital Place, Central Peninsula General Hospital, Soldotna, AK 99669 | |
(907) 714-4483 | |
(907) 714-4686 |
Full Name | Timothy A Gleason |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Location | 250 Hospital Place, Soldotna, Alaska |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902967482 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 2544 (Alaska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Timothy A Gleason, DO Po Box 241769, Anchorage, AK 99524-1769 Ph: (907) 770-2380 | Timothy A Gleason, DO 250 Hospital Place, Central Peninsula General Hospital, Soldotna, AK 99669 Ph: (907) 714-4483 |
News Archive
BioSante Pharmaceuticals, Inc. today announced that a New Drug Application (NDA) has been accepted for filing by the U.S. Food and Drug Administration (FDA) following submission in January 2011 by a subsidiary of Teva Pharmaceutical Industries Ltd.. The FDA has assigned a PDUFA date of November 14, 2011. The PDUFA date is the target date for the FDA to complete its review of the NDA.
A new study of young people experiencing a first episode of psychosis reports elevations in the brain chemicals glutamate and glycine. Published in Biological Psychiatry, the study led by Dr. Dost öngür of Harvard Medical School provides the first-ever measurement of glycine levels in patients with psychotic disorders.
DaVita HealthCare Partners Inc., one of the nation's largest and most innovative health care communities, was recently recognized by the Congressional Black Caucus Foundation with the 2014 CBC Fall Health Braintrust Corporate Leadership Award.
Oxygen Biotherapeutics, Inc. today announced it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Naval Medical Research Center (NMRC) to conduct preclinical trials to assess the safety and efficacy of Oxygen Biotherapeutics' proprietary Oxycyte perfluorocarbon emulsion (PFCE) for the prevention and treatment of decompression sickness and related injuries.
Researchers from The Miriam Hospital have found that people with Chronic obstructive pulmonary disease (COPD) who are also depressed have difficulty sticking to a pulmonary rehabilitation program.
› Verified 1 days ago
Gregg Motonaga, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 250 Hospital Pl, Soldotna, AK 99669 Phone: 907-714-4404 | |
Dr. Justin P Evans, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 250 Hospital Pl, Soldotna, AK 99669 Phone: 907-714-4404 | |
Dr. Lindsay Brianne Cobb, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 250 Hospital Pl, Soldotna, AK 99669 Phone: 907-714-4502 Fax: 907-714-4696 | |
Cory Deon Jones, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 250 Hospital Pl, Soldotna, AK 99669 Phone: 907-714-4529 Fax: 907-714-4596 |